SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 780.70 |
Enterprise Value ($M) | 709.73 |
Book Value ($M) | 230.76 |
Book Value / Share | 2.39 |
Price / Book | 3.38 |
NCAV ($M) | 229.30 |
NCAV / Share | 2.38 |
Price / NCAV | 3.40 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.24 |
Return on Assets (ROA) | -0.20 |
Return on Equity (ROE) | -0.21 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 96.92 |
Current Ratio | 96.92 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 231.73 |
Assets | 233.19 |
Liabilities | 2.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.03 |
Operating Income | -67.52 |
Net Income | -54.37 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -59.27 |
Cash from Investing | -87.18 |
Cash from Financing | 6.90 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Ra Capital Management, L.p. | 11.30 | 14.81 | |
13G/A | Fmr Llc | 1.25 | -77.61 | |
13D/A | Bell Robert G. | 4.50 | -49.63 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
118,354 | 520,298 | 22.75 | |
93,452 | 196,262 | 47.62 | |
52,484 | 156,334 | 33.57 | |
116,015 | 209,455 | 55.39 | |
(click for more detail) |
Similar Companies | |
---|---|
SLGL – Sol-Gel Technologies Ltd. | SMMT – Summit Therapeutics Inc. |
SNSE – Sensei Biotherapeutics, Inc. | STRO – Sutro Biopharma, Inc. |
SUPN – Supernus Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io